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Understanding the impact of socioeconomic differences
in colorectal cancer survival: potential gain in life-years
Elisavet Syriopoulou 1, Eva Morris2, Paul J. Finan2, Paul C. Lambert1,3 and Mark J. Rutherford1
BACKGROUND: Colorectal cancer prognosis varies substantially with socioeconomic status. We investigated differences in life
expectancy between socioeconomic groups and estimated the potential gain in life-years if cancer-related survival differences
could be eliminated.
METHODS: This population-based study included 470,000 individuals diagnosed with colon and rectal cancers between 1998 and
2013 in England. Using ﬂexible parametric survival models, we obtained a range of life expectancy measures by deprivation status.
The number of life-years that could be gained if differences in cancer-related survival between the least and most deprived groups
were removed was also estimated.
RESULTS: We observed up to 10% points differences in 5-year relative survival between the least and most deprived. If these
differences had been eliminated for colon and rectal cancers diagnosed in 2013 then almost 8231 and 7295 life-years would have
been gained respectively. This results for instance in more than 1-year gain for each colon cancer male patient in the most deprived
group on average. Cancer-related differences are more profound earlier on, as conditioning on 1-year survival the main reason for
socioeconomic differences were factors other than cancer.
CONCLUSION: This study highlights the importance of policies to eliminate socioeconomic differences in cancer survival as in this
way many life-years could be gained.
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BACKGROUND
Although overall colorectal cancer survival rates are improving there
is substantial variation by deprivation, age and to some extent sex.
Previous studies investigating inequalities among socioeconomic
groups showed that the most deprived group have a signiﬁcantly
worse prognosis after diagnosis.1,2 The deprivation gap is unlikely to
be explained entirely by differences in tumour characteristics.3 In a
randomised clinical trial, in which equal treatment was provided, the
deprivation inequalities were reduced suggesting that other factors
related to the healthcare system, such as access to treatment, might
account for the variation seen.4
To understand the impact of eliminating inequalities on
patients’ whole lifespan, loss in life expectancy measures can be
used. Loss in life expectancy due to a cancer diagnosis is deﬁned
as the reduction in life expectancy following a cancer diagnosis
and is given as the difference of the life expectancy in the general
population that is free of the cancer of interest and the life
expectancy in the population of cancer patients.5 In comparison
with the commonly reported measure of relative survival that
estimates survival in a hypothetical world, where the only possible
cause of death is the cancer of interest, loss in life expectancy is an
intuitive measure that makes communication of cancer survival
easier.6 It is a measure of great interest in public health as it can be
used to quantify the disease burden in society and to address
various research questions such as the impact of cancer diagnosis
on life expectancy among different populations.7
In addition to absolute estimates of loss in life expectancy other
measures can also be estimated. The proportion of life lost
provides a measure for the impact of cancer that depends less on
age and accounts for the fact that younger patients have more
years to lose. Conditional measures can also be obtained to
provide an updated estimate of prognosis for patients who
survived a certain number of years. Moreover, total life-years lost
based on a speciﬁc year’s number of diagnoses is useful for
estimating the population impact of cancer.8
This study estimated the impact of colon and rectal cancers
on patients’ life expectancy across socioeconomic groups in
England using a range of reporting measures. It also quantiﬁed
the number of life-years that could be gained if differences in
cancer-related survival between the least and most deprived
groups were removed. Proportional and conditional measures are
also provided.
METHODS
Data resources
This retrospective population-based study includes all patients
diagnosed with colon and rectal cancers from 1998 until 2013 in
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England. Data were obtained from National Cancer Registration and
Analysis Service within Public Health England. International Classi-
ﬁcation of Diseases 10 was used to identify colon cancer (C18)
and rectal cancer (C19, C20). Each patient was assigned to one
out of ﬁve deprivation groups. The information on deprivation
status is a weighted average based on national quantiles of
the index of multiple deprivation (IMD) 2010 score based on the
patients’ residence at diagnosis and is not an individual speciﬁc
measure.9,10
Statistical methods
A ﬂexible parametric relative survival model was ﬁtted separately
for colon and rectal cancers as well as males and females. Flexible
parametric models use restricted cubic splines to model the
baseline excess hazard.11,12 In our analysis, 5 degrees of freedom
were considered to model the log cumulative baseline excess
hazard allowing for 6 knots for the splines. Knots are points at
which the splines join. Age at diagnosis was included in the model
as a continuous variable and a non-linear effect was allowed by
using restricted cubic splines with 3 degrees of freedom. As it is
common in population-based cancer studies to have a larger
effect of age on excess mortality earlier in follow-up, time-
dependent effects (non-proportional excess hazards) for age, were
also included in the models assuming 3 degrees of freedom. The
models also included the main and time-dependent effect of
deprivation status (3 degrees of freedom for the time-dependent
effect) and an interaction between age and deprivation status to
allow a differential effect of age across the deprivation groups.
A period window from the beginning of year 2007 to the end of
year 2013 was used, allowing only for the follow-up time during
this window to be included in the analysis. In period analysis,
patients that were diagnosed further back in the follow-up
and were still under follow-up during the period window
contribute to long-term survival estimates whereas survival of
patients that were diagnosed recently is used for short-term
survival. In this way, better estimates for newly diagnosed patients
are obtained.13,14
Relative survival is deﬁned as the all-cause survival divided by
the expected survival in the general population that is free of
the cancer of interest and has similar characteristics with the
cancer population. Expected survival rates were incorporated
in the models by using population mortality life tables stratiﬁed
by sex, age at diagnosis, calendar year, and deprivation status.15
For each model, estimates of relative survival, loss in life
expectancy, proportion of life lost and conditional loss in loss in
life expectancy given that patients survived 1 year after their
diagnosis by deprivation group were obtained. The proportion
of life lost was calculated as the loss in life expectancy divided
by the expected life expectancy. The conditional measure of
loss in life expectancy was used to assess whether cancer
differences remain after 1 year of survival. The total years lost
due to cancer diagnosis across deprivation groups in England
in 2013, the most recent year in the available data, was obtained
by multiplying the number of patients diagnosed with colon or
rectal cancer in 2013 with the average loss in life expectancy. The
average loss in life expectancy was calculated as a weighted
average of the age-speciﬁc estimates within each deprivation
group.
The impact of eliminating inequalities in cancer-related survival
across socioeconomic groups was then estimated. First, the above
loss in life expectancy measures were estimated once more using
the relative survival estimates of the least deprived group for all
the other deprivation groups. Subsequently, the difference
between estimates where each group was allowed to have their
own relative survival and estimates obtained under the scenario
that a group’s relative survival was the same as the relative
survival of the least deprived group were produced. By using the
relative survival of the least deprived group it was then possible to
quantify the potential gain in life-years if cancer-related differ-
ences in survival could be removed.
RESULTS
The analysis included more than 300,000 and 170,000 patients
diagnosed with colon and rectal cancer respectively. Female
colon cancer patients were diagnosed at a slightly older age in
comparison with male patients, with an average age of 71 years
for males and 73 years for women. A similar pattern was observed
for rectal cancer with the average age being 69 and 71 years old
for male and female patients respectively (Table 1).
Table 2 shows the 5-year relative survival estimates of males
diagnosed with colon cancer at speciﬁc ages by deprivation
group. Differences in relative survival between the least and the
most deprived groups remained above 5.5% points and in favour
of the most afﬂuent group for all ages considered. The highest
difference was observed for patients diagnosed at the age of 60,
where 5-year relative survival was 65.87% for the least and 56.35%
for the most deprived patients. Similarly, large differences in
relative survival were observed for females with colon cancer as
well as rectal cancer (Supplementary Tables 1, 2, and 3). Table 2
and Supplementary Tables 1, 2, and 3 also show that relative
survival remains at similar levels for ages 50, 60, and 70 years old
but a larger decrease is observed for those diagnosed at 80 years
old.
Loss in life expectancy after a colon cancer diagnosis varies by
age at diagnosis and deprivation group (Table 2). Larger
differences are observed across socioeconomic groups. For
example, 60-year-old males in the general population that are
free of colon cancer are expected to live on average for 24.43
years if they belong to the least deprived group and 19.42 years if
they belong in the most deprived group. A cancer diagnosis at
that age however may result in a decrease in life expectancy and
is estimated that the least deprived will have a life expectancy of
14.89 years and the equivalent life expectancy for the most
deprived is 10.38 years. The proportion of life lost is signiﬁcantly
Table 1. Number and mean age of patients diagnosed with colon and
rectal cancer from 1998 until 2013 in England by deprivation status for
males and females
Cancer type Gender Deprivation group Number of
patients
Mean age
(years)
Colon Males Least deprived 32,079 70.66
2 34,187 71.23
3 32,618 71.34
4 29,593 71.14
Most deprived 25,855 70.20
Females Least deprived 28,687 71.98
2 32,140 73.00
3 31,885 73.32
4 29,186 73.33
Most deprived 24,167 72.39
Rectal Males Least deprived 21,125 68.57
2 22,542 69.19
3 22,411 69.43
4 20,858 69.31
Most deprived 19,029 68.62
Females Least deprived 12,995 70.08
2 14,500 70.96
3 14,403 71.52
4 13,414 71.58
Most deprived 11,484 70.73
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higher for the most deprived patient. Loss in life expectancy
caused after diagnosis results in 39.04% loss in the expected
remaining life of the least deprived patient and 46.55% for the
most deprived. However, by eliminating the differences in cancer-
related survival and therefore forcing the relative survival of the
most deprived to the be the same as for the least deprived
patients, the proportion of life lost for the most deprived
decreases to 37.56%. This is even smaller than the equivalent
proportion of the most afﬂuent patients. Such high differences in
loss in life expectancy are observed also for females and rectal
cancer with females are losing more years than men (Supple-
mentary Tables 1, 2, and 3).
The impact of cancer on a population level is estimated in
Table 3. For males with colon cancer, there were 6.76 and 6.98
years lost on average for the least and most deprived patients
respectively. Based on the number of patients diagnosed with
the disease in 2013, this accounts for 16,431 life-years lost among
the least deprived and 11,914 life-years lost among the most
deprived patients. However, if cancer-related differences in
survival were eliminated and the relative survival of the most
afﬂuent group was applied to the most deprived then the least
deprived would lose 9977 life-years i.e., 1937 life-years could
be gained for a cohort size and composition of those diagnosed
in 2013. The most deprived females could also gain 1854 years.
For rectal cancer, the equivalent gain for the most deprived
would be 1739 years for males and 1157 years for females.
By eliminating difference in all deprivation groups, there would
be 4270 and 3961 life-years gained in total for males and
females respectively (Figs. 1 and 2). Similarly, for rectal cancer
there would be 4348 life-years and 2947 life-years gained for
males and females respectively. As it is shown in Supplementary
Figs. 1 and 2, rectal cancer results in a smaller number of total life-
years lost in comparison with colon cancer due to the smaller
number of patients diagnosed with rectal cancer in 2013, even
though the average loss in life expectancy is slightly higher for
rectal cancer.
Table 2. Years lost by deprivation group if male colon cancer patients diagnosed at the ages of 50, 60, 70, 80 years old had (i) their own relative
survival and (ii) the same relative survival as the least deprived group
RS= As least deprived group
Deprivation group 5-year RS Mean years w/o cancer Mean years with cancer Prop (%) Mean years with cancer Prop (%) Years gained
Age-at-diagnosis: 50
Least deprived 65.21 33.58 19.92 40.67 19.92 40.67 0.00
2 62.08 32.30 18.51 42.69 19.24 40.43 0.73
3 61.08 31.11 17.58 43.49 18.59 40.23 1.01
4 60.30 29.39 16.95 42.32 17.66 39.92 0.70
Most deprived 55.87 27.30 14.15 48.17 16.51 39.53 2.36
Age-at-diagnosis: 60
Least deprived 65.87 24.43 14.89 39.04 14.89 39.04 0.00
2 63.71 23.30 13.94 40.17 14.28 38.69 0.34
3 61.73 22.35 12.98 41.93 13.76 38.43 0.78
4 59.20 20.97 11.98 42.86 13.00 38.02 1.01
Most deprived 56.35 19.42 10.38 46.55 12.13 37.56 1.75
Age-at-diagnosis: 70
Least deprived 63.02 16.08 9.81 38.99 9.81 38.99 0.00
2 61.26 15.12 9.11 39.78 9.30 38.49 0.20
3 60.03 14.49 8.59 40.73 8.95 38.22 0.36
4 56.90 13.56 7.78 42.60 8.44 37.77 0.65
Most deprived 54.74 12.66 6.94 45.15 7.93 37.36 0.99
Age-at-diagnosis: 80
Least deprived 50.96 9.35 5.04 46.06 5.04 46.06 0.00
2 50.26 8.62 4.66 46.00 4.71 45.34 0.06
3 50.45 8.35 4.53 45.72 4.58 45.14 0.05
4 47.96 7.92 4.16 47.46 4.38 44.77 0.21
Most deprived 45.32 7.69 3.81 50.40 4.25 44.67 0.44
Table 3. Total years lost, for colon and cancer patients, based on 2013
diagnosis if patients had (i) their own relative survival or (ii) the same
relative survival as the least deprived group, by gender and
deprivation group
RS= As least deprived group
Deprivation group Group size
in 2013
Mean
life years
lost
Total life
years lost
Mean life
years
lost
Total life
years lost
Life
years
gained
Colon cancer
Males
Least deprived 2430 6.76 16,431 6.76 16,431 0
2 2443 6.47 15,808 6.26 15,289 519
3 2324 6.45 14,992 6.10 14,169 823
4 2039 6.44 13,138 5.96 12,147 991
Most deprived 1708 6.98 11,914 5.84 9977 1937
Females
Least deprived 2053 7.32 15,022 7.32 15,022 0
2 2217 6.85 15,178 6.76 14,996 182
3 2065 7.24 14,949 6.77 13,986 963
4 1845 7.24 13,357 6.72 12,395 962
Most deprived 1483 7.96 11,804 6.71 9950 1854
Rectal cancer
Males
Least deprived 1464 7.10 10,384 7.10 10,384 0
2 1499 6.90 10,412 6.50 9790 622
3 1395 6.90 9654 6.30 8745 909
4 1245 6.90 8553 6.00 7475 1078
Most deprived 1158 7.40 8534 5.90 6795 1739
Females
Least deprived 790 7.30 5761 7.30 5761 0
2 816 7.00 5714 6.80 5567 147
3 843 7.40 6265 6.40 5409 856
4 779 7.40 5784 6.40 4997 787
Most deprived 642 8.10 5208 6.30 4051 1157
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Table 4 shows the partitioning of differences in life expectancy
between the least and most deprived groups to that due to cancer
or due to other causes. For example, for two female patients
diagnosed with colon cancer at age 70 years old, one of whom
belong to the least and the other to the most deprived group, a
difference of 3.15 years in life expectancy is observed. If we could
eliminate the cancer-related differences, then a difference of 1.66
years would still be observed (Supplementary Table 1). Thus,
47.4% of the differences in prognosis of the two groups are due to
cancer and the remaining 52.6% are due to other causes. A similar
pattern is observed for all ages. As time since diagnosis increases
however the proportions differ signiﬁcantly. Given that the
previous 70-year-old patients survive 1 year after their diagnosis,
the differences we observed between them would mainly be
explained by causes different to their cancer. Speciﬁcally, cancer
accounts only for 28.2% of the differences whereas other causes
account for 71.8% of the observed differences. For older female
patients, a slightly higher proportion of differences could be
attributed to causes unrelated to cancer. Findings were similar for
male patients. For rectal cancer we observed the same pattern and
after conditioning on 1 year of survival cancer was explaining a
smaller proportion of the socioeconomic differences in compar-
ison with the unconditional estimates.
Finally, Supplementary Fig. 3, shows the loss in life expectancy
for a female patient diagnosed with colon cancer at the age of
70. For patients at that age who will survive their cancer for 1
year, the loss in life expectancy is estimated to be lower and
differences between the least and most deprived patients of this
age are also decreasing. The reduction in loss in life expectancy
of the patient can partly be explained by the fact that there are
less years to lose to begin with as the patient has already
survived for 1 year but are mostly explained by patients having
survived through the year following diagnosis, where the excess
mortality is high.
DISCUSSION
This study has provided a detailed summary on the impact of
colorectal cancer on patients’ life expectancy by socioeconomic
status using a data resource on all patients diagnosed in England.
Socioeconomic differences were quantiﬁed using measures of loss
in life expectancy that assess the impact of a cancer diagnosis on
the whole lifespan instead of a particular point in follow-up time
after diagnosis, such as 1-year or 5-year relative survival. To better
understand inequalities in prognosis, the potential gain in life-
years by eliminating differences between socioeconomic groups
was further explored. Removing cancer-related inequalities would
result in substantial gain in life-years and our results support the
importance of policies to target the most affected group and
remove socioeconomic inequalities. Updated estimates condition-
ing on 1-year survival were also obtained to help inform our
understanding of what drives the survival differences.
Results showed that each colon cancer male patient from the
most deprived group would gain 1.14 years of life on average. The
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Fig. 1 Number of male patients diagnosed with colon cancer in 2013, the average life years lost and the total years lost by deprivation group
(1 for the least deprived and 5 for the most deprived patients) as well as total years lost for all deprivation groups combined (plot in the
bottom) under two scenarios (i) if each group had their own relative survival (dark blue bar) and (ii) if each groups had the relative survival of
the least deprived group (light blue bar)
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equivalent gain for females was 1.25 years and for rectal cancer
was 1.5 and 1.8 years for males and females respectively. These
numbers varied signiﬁcantly with age at diagnosis. On a
population level, eliminating the differences across all deprivation
groups would result in almost 8231 and 7295 life-years gained
based on the number of colon and rectal cancer diagnoses in
2013, respectively.
Age at diagnosis has a strong impact on loss in life expectancy
and younger patients were found to lose noticeably more years of
their remaining life as they have more years to lose to begin with.
For example, a male colon cancer patient from the most deprived
group that was diagnosed at the age of 50 would lose 13.15 years
from his remaining life because of his diagnosis on average.
However, if this patient had the same cancer-related survival as a
similar patient from the least deprived group, he would have lost
10.79 years instead i.e., there would be 2.36 years gained. Potential
gain in life-years for the younger patients is particularly important,
as a number of studies had shown that the incidence of colon and
rectal cancer is increasing in the under 50 s.16–20
An intervention of eliminating differences may not be
straightforward in practice as many factors may account for the
differences. Even though England has a universal healthcare
system, there is evidence of differential treatment between
socioeconomic groups.21 Previous studies have also suggested
that stage at diagnosis may partially explain the differences.21,22
An evaluation of the population-based colorectal cancer screening
programme that was initiated in 2006 showed a striking gradient
by socioeconomic status with the uptake ranging from 35% in the
most deprived to 61% in the least deprived.23 Another study
indicated that emotional and practical barriers, which could affect
screening decision making, were strongly negatively associated
with education. If diagnosis in a more advance stage accounts for
some of the inequalities, then action to promote informed uptake
of screening could be implemented.24 Other possible factors that
may inﬂuence survival are lifestyle, health-seeking behaviours as
some people are more prone to seek medical care and
comorbidities.25–27 Controlling for all the factors that drive
inequalities can be challenging. An advantage of our study is
that it focused on quantifying cancer-related differences rather
than all-cause differences. All-cause differences may be the result
of more complicated mechanisms that relates both to cancer and
other causes. In contrast, it may be easier to control for cancer-
related differences.
Our analysis, showed also that colon cancer accounts for
34–50% of the total differences observed in loss in life
expectancy depending on the age at diagnosis. However, as
time since diagnosis increases and, especially for the older
patients, other causes account for the majority of the observed
differences. When conditioning on 1-year survival, less than 32%
of the observed differences are due to colon cancer-related
differences and other causes dominate. Even when differences
in cancer survival are removed, the all-cause survival continues
to vary by deprivation group. A similar trend was observed for
rectal cancer.
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Fig. 2 Number of female patients diagnosed with colon cancer in 2013, the average life years lost and the total years lost by deprivation
group (1 for the least deprived and 5 for the most deprived patients) as well as total years lost for all deprivation groups combined (plot in the
bottom) under two scenarios (i) if each group had their own relative survival (dark blue bar) and (ii) if each groups had the relative survival of
the least deprived group (light blue bar)
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Loss in life expectancy is a useful measure for assessing the
impact of a cancer diagnosis in the whole of remaining life and it
yields real world estimates in which both cancer and other
causes of death may be present. Their simple interpretation
makes communication of cancer statistics to a broader audience
easier. Proportional and conditional measures can also be
estimated to provide different aspects of the cancer impact.
To estimate the population impact, the total life-years lost can
be calculated simply by choosing the number of patients
diagnosed in a typical year.
Even though loss in life expectancy measures provide useful
summaries of cancer, if interest lies in comparing cancer survival
between different populations or countries then relative survival
may be more appropriate. Relative survival accounts for different
background mortalities between populations as it refers to a
hypothetical world where the cancer of interest is the only
possible cause of death and other causes of death are not present.
In this paper, our aim was to provide estimates of the actual
impact on colon and rectal cancers in England and therefore loss
in life expectancy was more relevant as it incorporates other
causes of death that are present in the real world.
This study has demonstrated large differences in terms of
prognosis between socioeconomic groups. If these cancer-related
differences could be eliminated many life-years could be gained
for the most affected groups. Further investigation is now required
in order to explore the underlying determinants that drive
inequalities. A better understanding of mechanisms that generate
inequalities is essential as it would enable the implementation of
appropriate policies to eliminate them.
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